Danielle Hammond, MD, received her medical degree from the University of Ottawa in Ottawa, Canada. She the completed a residency in internal medicine at the University of Toronto in Toronto, Canada, followed by a residency in hematology at Queen’s University in Kingston, Canada.
Dr Hammond is currently a Clinical Fellow in the Department of Leukemia at the MD Anderson Cancer Center in Houston, TX.
Speaking on clonal hematopoiesis, MDS, AML and BMFs
Dr Hammond’s research is focused in the fields of clonal hematopoiesis, myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and bone marrow failure (BMF) syndromes. Dr Hammond has previously published papers on the use of next-generation sequencing in patients with cytopenias and has been involved in the QUAZAR AML-001 maintenance trial.